Peptide Drugs intermediate
Insulin Degludec/Aspart: Therapeutic Peptide Drug Profile
Premixed insulin with 70% insulin degludec (long-acting) and 30% insulin aspart (rapid-acting). Provides both basal and prandial coverage. Indication: Type 2...
By Encyclopeptide Editorial | 1 min read
insulin-degludec-aspart peptide-drug therapeutic
Chemical Identity
| Property | Value |
|---|---|
| Name | Insulin Degludec/Aspart |
| Description | Premixed insulin with 70% insulin degludec (long-acting) and 30% insulin aspart (rapid-acting). Provides both basal and prandial coverage. Indication: Type 2… |
Mechanism of Action
Premixed insulin with 70% insulin degludec (long-acting) and 30% insulin aspart (rapid-acting). Provides both basal and prandial coverage. Indication: Type 2…
Clinical Significance
This peptide drug has important therapeutic applications in clinical medicine.
References
- Encyclopeptide Database. “Insulin Degludec/Aspart” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Insulin Degludec/Aspart: Therapeutic Peptide Drug Profile with interactive quizzes on Wikipept.
Take a Quiz on Wikipept